Programs are mRNA vaccine candidates against herpes simplex virus, varicella-zoster virus to reduce the rate of shingles and new checkpoint cancer vaccine.
To leverage Carterra’s LSA platform to screen hundreds of antibodies in a few days as CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks